Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting.

Int J Mol Sci · 2025 · PMC12154572 · PMID 40508118

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients whose tumors presented with two or more concomitant AVPC-TSG alterations (n = 7) showed a trend towards a higher risk of progression and death compared to those with only one alteration (n = 56), as shown in Table S8 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.